Investment Summary

Boston Millennia Partners Invests In GlycoFi

On January 1, 2006, growth capital firm Boston Millennia Partners invested in life science company GlycoFi

Investment Highlights
  • This is Boston Millennia Partners’ 4th transaction in the Life Science sector.
  • This is Boston Millennia Partners’ 7th transaction in the United States.
  • This is Boston Millennia Partners’ 1st transaction in New Hampshire.
Investment Fate
  • GlycoFi was sold to a strategic buyer in 2006 for 400M USD.

Investment Summary

Date 2006-01-01
Target GlycoFi
Sector Life Science
Investor(s) Boston Millennia Partners
Deal Type Venture

Target

GlycoFi

Lebanon, New Hampshire, United States
GlycoFi, Inc., is specialized in a protein-making process called yeast glyco engineering, a process that is considered faster than more conventional methods of making protein-based drugs. GlycoFi was founded in 2000 and is based in Lebanon, New Hampshire.

Search 214,981 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor
DESCRIPTION

Boston Millenia Partners is a growth capital investment firm focused rapidly growing business services and healthcare companies. The Firm generally looks to invest $3 to $10 million in companies at or near profitability with $3 to $30 million in sales. Boston Millenia's geographic preference is for opportunities in the Eastern half of the US. Boston Millenia Partners was formed in 1984 and has a single office in Boston.


DEAL STATS #
Overall 7 of 16
Sector: Life Science M&A 4 of 4
Type: Venture M&A Deals 7 of 9
State: New Hampshire M&A 1 of 1
Country: United States M&A 7 of 15
Year: 2006 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-01-01 Histogenics

Waltham, Massachusetts, United States

Histogenics is a regenerative medicine company that combines cell therapy and tissue engineering technologies to develop highly innovative products for tissue repair and regeneration. Histogenics was founded in 2000 and is based in Waltham, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-02-28 WebCT

Lynnfield, Massachusetts, United States

WebCT, Inc. is a provider of e-learning software company serving the education industry. WebCT was founded in 1995 and is based in Lynnfield, Massachusetts.

Sell $178M